litlas
Log inCreate account

Alan S. Perelson

Active 1971–2026

280
Papers
62,818
Citations
125
h-index
269
i10-index

Citations

Citations per year for Alan S. Perelson1972: 1 citations1973: 5 citations1974: 5 citations1975: 1 citations1976: 3 citations1977: 4 citations1978: 8 citations1979: 4 citations1980: 5 citations1981: 1 citations1982: 3 citations1983: 5 citations1984: 4 citations1985: 7 citations1986: 6 citations1987: 5 citations1988: 18 citations1989: 17 citations1990: 22 citations1991: 36 citations1992: 35 citations1993: 64 citations1994: 58 citations1995: 99 citations1996: 208 citations1997: 277 citations1998: 321 citations1999: 359 citations2000: 474 citations2001: 385 citations2002: 511 citations2003: 540 citations2004: 525 citations2005: 593 citations2006: 513 citations2007: 632 citations2008: 579 citations2009: 664 citations2010: 802 citations2011: 802 citations2012: 726 citations2013: 778 citations2014: 665 citations2015: 616 citations2016: 562 citations2017: 422 citations2018: 563 citations2019: 1,152 citations2020: 1,252 citations2021: 1,220 citations2022: 691 citations2023: 617 citations2024: 1,003 citations2025: 425 citations2026: 40 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,358 citing papers, 33.4% of this breakdownUnited Kingdom: 1,186 citing papers, 7.4% of this breakdownChina: 1,098 citing papers, 6.8% of this breakdownFrance: 711 citing papers, 4.4% of this breakdownGermany: 699 citing papers, 4.4% of this breakdownCanada: 587 citing papers, 3.7% of this breakdownAustralia: 469 citing papers, 2.9% of this breakdownItaly: 424 citing papers, 2.6% of this breakdownNetherlands: 362 citing papers, 2.3% of this breakdownIndia: 351 citing papers, 2.2% of this breakdownSpain: 336 citing papers, 2.1% of this breakdownSwitzerland: 307 citing papers, 1.9% of this breakdown
0%33.4%Other 25.9%

Institutions

Fields

  • Immunology and Microbiology30.9%
  • Medicine29.8%
  • Engineering11.6%
  • Biochemistry, Genetics and Molecular Biology9.3%
  • Computer Science8.1%
  • Mathematics5.5%
  • Other4.8%

Topics

  • HIV Research and Treatment10.8%
  • Immune Cell Function and Interaction5.6%
  • HIV/AIDS drug development and treatment4.6%
  • HIV/AIDS Research and Interventions3.8%
  • Mathematical and Theoretical Epidemiology and Ecology Models3.8%
  • Artificial Immune Systems Applications3.7%
  • Other67.7%

Coauthors

All papers

Open in search
  1. Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis

    Authors: Vladimir A. Kuznetsov, Iliya A. Makalkin, Mark A. Taylor, Alan S. Perelson - Bulletin of Mathematical Biology 1994 cited by 916

  2. On Identifiability of Nonlinear ODE Models and Applications in Viral Dynamics

    Authors: Hongyu Miao, Xiaohua Xia, Alan S. Perelson, Hulin Wu - SIAM Review, SIAM Rev. 2011 cited by 624

  3. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

    Authors: Alan S. Perelson, Avidan U. Neumann, Martin Markowitz, John M. Leonard, David D. Ho - Science 1996 cited by 3,563

  4. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

    Authors: Natalie F. McMyn, Joseph Varriale, Emily J. Fray, Carolin Zitzmann, H. H. B. Macleod, Jun Lai, Anushka Singhal, Milica Moskovljevic, Mauro Garcia, Brianna Lopez, Vivek Hariharan, Kyle Rhodehouse, Kenneth Lynn, Pablo Tebas, Karam Mounzer, Luis J. Montaner, Erika Benko, Colin Kovacs, Rebecca Hoh, Francesco R. Simonetti, Gregory M. Laird, Steven G. Deeks, Ruy M. Ribeiro, Alan S. Perelson, Robert F. Siliciano, Janet D. Siliciano - Journal of Clinical Investigation 2023 cited by 132

  5. Mathematical Analysis of HIV-1 Dynamics in Vivo

    Authors: Alan S. Perelson, Patrick W. Nelson - SIAM Review, SIAM Rev. 1999 cited by 1,561

  6. Kinetics of Influenza A Virus Infection in Humans

    Authors: Prasith Baccam, Catherine A. A. Beauchemin, Catherine A. Macken, Frederick G. Hayden, Alan S. Perelson - Journal of Virology 2006 cited by 808

  7. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

    Authors: Brandon F. Keele, Elena E. Giorgi, Jesus F. Salazar-Gonzalez, Julie M. Decker, Kimmy T. Pham, Maria G. Salazar, Chuanxi Sun, Truman Grayson, Shuyi Wang, Hui Li, Xiping Wei, Chunlai Jiang, Jennifer Kirchherr, Feng Gao, Jeffery A. Anderson, Li-Hua Ping, Ronald Swanstrom, Georgia D. Tomaras, William A. Blattner, Paul Goepfert, J Michael Kilby, Michael S. Saag, Eric Delwart, Michael P. Busch, Myron S. Cohen, David C. Montefiori, Barton F. Haynes, Brian Gaschen, Gayathri S. Athreya, Ha Y. Lee, Natasha T. Wood, Cathal Seoighe, Alan S. Perelson, Tanmoy Bhattacharya, Bette Korber, Beatrice H. Hahn, George M. Shaw - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 1,937

  8. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues

    Authors: Courtney V. Fletcher, K A Staskus, Stephen W. Wietgrefe, Meghan Rothenberger, Cavan Reilly, Jeffrey G. Chipman, Gregory J. Beilman, Alexander Khoruts, Ann Thorkelson, Thomas Schmidt, Jodi Anderson, Katherine Perkey, Mario Stevenson, Alan S. Perelson, Daniel C. Douek, Ashley T. Haase, Timothy W. Schacker - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 655

  9. Dynamics of HIV infection of CD4+ T cells

    Authors: Alan S. Perelson, Denise E. Kirschner, Rob J. de Boer - Mathematical Biosciences 1993 cited by 984

  10. Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

    Authors: Kathryn E. Stephenson, Boris Jülg, Chen Sabrina Tan, Rebecca Zash, Stephen R. Walsh, Charlotte-Paige Rolle, Ana Monczor, Sofia Lupo, Huub C. Gelderblom, Jessica L. Ansel, Diane G. Kanjilal, Lori F. Maxfield, Joseph P. Nkolola, Erica N. Borducchi, Peter Abbink, Jinyan Liu, Lauren Peter, Abishek Chandrashekar, Ramya Nityanandam, Zijin Lin, Alessandra C. Setaro, Joseph Sapiente, Zhilin Chen, Lisa Sunner, Tyler Cassidy, Chelsey Bennett, Alicia Sato, Bryan T. Mayer, Alan S. Perelson, Allan C. deCamp, Frances Priddy, Kshitij Wagh, Elena E. Giorgi, Nicole L. Yates, Roberto C. Arduino, Edwin DeJesus, Georgia D. Tomaras, Michael S. Seaman, Bette Korber, Dan H. Barouch - Nature Medicine 2021 cited by 102

  11. Decay characteristics of HIV-1-infected compartments during combination therapy

    Authors: Alan S. Perelson, Paulina Essunger, Yunzhen Cao, Mika Vesanen, Arlene Hurley, Kalle Saksela, Martin Markowitz, David D. Ho - Nature 1997 cited by 1,905

  12. Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load

    Authors: António Gonçalves, Julie Bertrand, Ruian Ke, Emmanuelle Comets, Xavier de Lamballerie, Denis Malvy, Andrés Pizzorno, Olivier Terrier, Manuel Rosa‐Calatrava, France Mentré, Patrick F. Smith, Alan S. Perelson, Jérémie Guedj - CPT Pharmacometrics & Systems Pharmacology 2020 cited by 237

  13. Modelling viral and immune system dynamics

    Authors: Alan S. Perelson - Nature reviews. Immunology 2002 cited by 980

  14. Variable efficacy of repeated annual influenza vaccination

    Authors: Derek J. Smith, Stephanie Forrest, David H. Ackley, Alan S. Perelson - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 411

  15. Post-treatment control of HIV infection

    Authors: Jessica M. Conway, Alan S. Perelson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 243

  16. Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy

    Authors: Jennifer A. White, Francesco R. Simonetti, Subul Beg, Natalie F. McMyn, Weiwei Dai, Niklas Bachmann, Jun Lai, William C. Ford, Christina Bunch, Joyce Jones, Ruy M. Ribeiro, Alan S. Perelson, Janet D. Siliciano, Robert F. Siliciano - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 97

  17. Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

    Authors: Manish C. Choudhary, Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain, Carlee Moser, Michael D. Hughes, Justin Ritz, Ruy M. Ribeiro, Ruian Ke, Joan Dragavon, Arzhang Cyrus Javan, Ajay Nirula, Paul Klekotka, Alexander L. Greninger, Courtney V. Fletcher, Eric S. Daar, David A. Wohl, Joseph J. Eron, Judith S. Currier, Urvi M. Parikh, Scott F. Sieg, Alan S. Perelson, Robert W. Coombs, Davey M. Smith, Jonathan Z. Li, for the ACTIV-2/A5401 Study Team, David R. Smith, Arzhang Cyrus Javan, Mark J Giganti, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott F. Sieg, William A. Fischer, Teresa H. Evering, Rachel Bender Ignacio, Sandra Wagner Cardoso, Katya Corado, Prasanna Jagannathan, Nikolaus Jilg, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi - Nature Microbiology 2022 cited by 53

  18. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

    Authors: David D. Ho, Avidan U. Neumann, Alan S. Perelson, Wen Chen, John M. Leonard, Martin Markowitz - Nature 1995 cited by 4,298

  19. Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Authors: Georgia D. Tomaras, Nicole L. Yates, Pinghuang Liu, Qin Li, Genevieve G. Fouda, L. L. Chavez, Allan C. deCamp, Robert Parks, Vicki C Ashley, Judith T. Lucas, Myron S. Cohen, Joseph J. Eron, Charles B. Hicks, Hua-Xin Liao, Steven G. Self, Gary Landucci, Donald N. Forthal, Kent J. Weinhold, Brandon F. Keele, Beatrice H. Hahn, Michael Greenberg, Lynn Morris, Salim S. Abdool Karim, William A. Blattner, David C. Montefiori, George M. Shaw, Alan S. Perelson, Barton F. Haynes - Journal of Virology 2008 cited by 624

  20. A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2

    Authors: Kwang Su Kim, Keisuke Ejima, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, Yusuke Asai, Shinji Nakaoka, Koichi Watashi, Kazuyuki Aihara, Robin N. Thompson, Ruian Ke, Alan S. Perelson, Shingo Iwami - PLoS Biology 2021 cited by 169

  21. Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy

    Authors: Avidan U. Neumann, Nancy P. Lam, Harel Dahari, David R. Gretch, Thelma E. Wiley, Thomas J. Layden, Alan S. Perelson - Science 1998 cited by 2,120

  22. Quantifying T lymphocyte turnover

    Authors: Rob J. de Boer, Alan S. Perelson - Journal of Theoretical Biology 2013 cited by 252

  23. Self-nonself discrimination in a computer

    Authors: Stephanie Forrest, Alan S. Perelson, Lawrence Allen, Rajesh Cherukuri - Computer Society Symposium on Research in Security and Privacy, S&P 1994 cited by 1,330

  24. Mechanistic Modeling of SARS‐CoV‐2 and Other Infectious Diseases and the Effects of Therapeutics

    Authors: Alan S. Perelson, Ruian Ke - Clinical Pharmacology & Therapeutics 2021 cited by 109